CAS: 306959-01-3
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide REF: IN-DA01C0KFCAS: 306959-01-3 | 95% | 81,00 €~509,00 € | Mo 25 Nov 24 |
 | MYLS22 REF: TM-T9127CAS: 306959-01-3 | 98.82% - 99.77% | 41,00 €~862,00 € | Mo 02 Dez 24 |
 | MYLS22 REF: 3D-GMA95901CAS: 306959-01-3 | Min. 95% | Nachfragen | Di 07 Jan 25 |
![N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyra…](https://static.cymitquimica.com/products/IN/thumb/DA01C0KF.jpg)
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide
CAS:306959-01-3
Formel:
C24H21N5O2S
Reinheit:
95%
Molekulargewicht:
443.5208
Ref: IN-DA01C0KF
| 5mg | 81,00 € | ||
| 25mg | 125,00 € | ||
| 50mg | 198,00 € | ||
| 100mg | 226,00 € | ||
| 250mg | 509,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 25. November 2024
MYLS22
CAS:306959-01-3
MYLS22: selective OPA1 inhibitor, halts tumor growth & angiogenesis, affects NFkB & gene expression, anti-cancer …
Formel:
C24H21N5O2S
Reinheit:
98.82% - 99.77%
Farbe und Form:
Solid
Molekulargewicht:
443.52
Ref: TM-T9127
| 2mg | 41,00 € | ||
| 5mg | 62,00 € | ||
| 10mg | 94,00 € | ||
| 25mg | 160,00 € | ||
| 50mg | 235,00 € | ||
| 100mg | 366,00 € | ||
| 200mg | 545,00 € | ||
| 500mg | 862,00 € | ||
| 1mL*10mM (DMSO) | 69,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 2. Dezember 2024
MYLS22
CAS:306959-01-3
Versatile small molecule scaffold
Formel:
C24H21N5O2S
Reinheit:
Min. 95%
Molekulargewicht:
443.5 g/mol
Ref: 3D-GMA95901
| 50mg | 245,00 € | ||
| 500mg | 974,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 7. Januar 2025
